BGPT: Paper Review: Interaction of the breast cancer resistance protein with plant polyphenols

Explore by Goal

Quick Explanation Copied

Core finding (directly from the paper)

Across two BCRP/ABCG2-overexpressing cell models, five plant polyphenols (silymarin, hesperetin, quercetin, daidzein) and the stilbene resveratrol increased intracellular accumulation of two BCRP substrates (mitoxantrone; BODIPY-FL prazosin), matching the direction expected for inhibition of BCRP-mediated efflux; the same polyphenols also stimulated BCRP-associated, vanadate-inhibitable ATPase activity in a BCRP-containing inside-out vesicle system (Lactococcus lactis), supporting direct transporter interaction.

Evidence:

Long Explanation

Paper review: Interaction of BCRP/ABCG2 with plant polyphenols

Biochemical & Biophysical Research Communications (2004). DOI: 10.1016/j.bbrc.2004.03.040

Methods → Cell efflux assays + ATPase in inside-out vesicles Compounds: quercetin, hesperetin, silymarin, daidzein, resveratrol BCRP substrates: mitoxantrone; BODIPY-FL prazosin

1) What the paper actually shows (data-grounded)

Specificity to BCRP expression: The polyphenols increased intracellular substrate accumulation in BCRP-overexpressing lines (MCF7/MR; K562/BCRP) but not in wild-type parental lines (MCF7/WT; K562).
Magnitude & ranking (from the provided tables): In MCF7/MR cells (Table 1), quercetin and silymarin produce strong accumulation increases vs substrate-only; hesperetin and resveratrol produce smaller but still significant increases vs control (as described in the paper).
Transporter mechanism support (ATPase stimulation): In BCRP-containing inside-out vesicles from Lactococcus lactis, polyphenols stimulated vanadate-inhibitable ATPase activity, and the paper notes that interpretation should be careful because ATPase stimulation does not always equal net transport.

2) Quantitative visualization (from Table 1 & Table 2)

How to read: The charts below use the paper’s reported median fluorescence values as a proxy for intracellular accumulation. I compute a simple “fold vs substrate-only” ratio using the table medians. This preserves the paper’s measured directionality but does not convert to absolute intracellular concentration.

Citation for the values used in charts: Table 1 and Table 2 median fluorescence values are reported in the paper.

3) ATPase stimulation landscape (ratios reported by the paper)

The paper reports stimulation ratios (mean ± SE) at 25 µM and notes that ATPase interpretation requires caution because ATPase stimulation does not always correlate with net transport.

4) Mechanistic claims: what’s supported vs what remains uncertain

Supported by the paper’s experiments

Polyphenols modulate BCRP functional readouts—directionally consistent with decreased efflux (increased intracellular accumulation) in BCRP-overexpressing mammalian cells, plus increased BCRP-associated, vanadate-inhibitable ATPase activity in the bacterial vesicle system.
Role of transporter activity is plausible, because a BCRP-specific inhibitor KO143 is used as a positive comparator in the accumulation assays and blocks stimulation in the ATPase assay context.

Not directly proven in this paper (known unknowns)

Direct transport of polyphenols: the paper explicitly states that conclusive proof of whether the polyphenols are directly transported would require direct transport assays.
Net-efflux mechanism from ATPase readout: the paper warns that ATPase stimulation does not always correlate with net substrate transport (e.g., hydrophobic substrates may create “futile cycles”).
Physiological relevance of concentrations: polyphenols were used at 30 µM in vitro. The paper argues this is within ranges used in previous in vitro studies, but it does not provide in vivo concentration measurements for gut luminal aglycones in the same experimental context.

5) Critical skepticism checklist (what could mislead)

Overexpression systems: BCRP-overexpressing lines (MCF7/MR and K562/BCRP) are not equivalent to endogenous tissue expression levels. The WT parental lines show no corresponding effects, which supports specificity, but absolute in vivo relevance still remains uncertain.
Transporter-independent fluorescence artifacts: The paper states flavonoids did not contribute intracellular fluorescence under their conditions and did not alter cell shape/size based on forward/side scatter profiles, which reduces (but cannot eliminate) concerns about measurement artifacts.
ATPase ≠ guaranteed inhibition of efflux: Polyphenols can stimulate ATPase activity while inhibiting net efflux via complex kinetics, or via substrate competition/“futile cycling”. The paper acknowledges this interpretive risk.

6) Context: how this fits with later ABCG2/“dietary phytochemical–transporter” work

Later work has identified additional dietary phytochemicals inhibiting ABCG2 (including flavonoids and other natural products), reinforcing the plausibility that diet-derived compounds can act on ABCG2/BCRP.

Resveratrol is also discussed across the MDR literature as a multi-target modulator, though such reviews synthesize heterogeneous studies and cannot substitute for direct, well-controlled mechanism confirmation.

Author reviews (jump out)

Use these BGPT links to see author-specific critical perspectives.

Feedback:

Updated: April 08, 2026